They will not be releasing results in the abstract and

New Post Public Reply Private Reply Replies (0) Message Board
TOB optionking #7326

They will not be releasing results in the abstract and poster. So it is unlikely to be "explosive" in respect to stunning results.

Now, whatever they share in March...all depends it can be explosive or a nonevent -optionking

However it is not a nonevent either.

They will present the outline of the Phase I trial to the research community at their key event for the first time. This is very important. They will no doubt cover the primary and secondary outcome measures and trial design, and can share at such information such as "Phase I studies may say, “Cohorts 1 and 2 have been completed without DLT . Enrollment to cohort 3 began in January 2011.”"

This could spur additional interest in the community for further research studies, draw more attention to the Phase I trial and Kevetrin, and lead to some interesting questions and discussions which are not restricted like the abstract and poster session.

(We should also keep in mind that by May 31 the trial will be further along and that will have been announced independent of ASCO)

This could indeed have and "explosive" effect in terms of additional interest from the research community. Although with trials and preclinical research already underway at 3 of the top cancer centers worldwide, and a fourth interested, it is fair to say the interest in Kevetrin is already explosive.

Here are all the details from ASCO about the Trials in Progress parameters. We should keep in mind that the abstract and poster will have been already submitted and current as of now, but they can submit amendments if things change.

http://chicago2013.asco.org/trials-progress

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

COP31 Puts China’s Weather-to-Energy Model on View

Updated Category News Views 76

Storm maps are becoming operating manuals, and that is the hard reality behind a November 13 COP31 event in Antalya, Türkiye. The session, “From Early Warning to Energy Action: Pathways for Global Climate Diplomacy and Cooperation,” put China’s effort to tie meteorological intelligence to energy-system decisions under an international spotlight. This is not...

Continue Reading
Teachstone’s Bronze Award Puts Classroom Quality in Focus

Updated Category News Views 0

Small Classroom Moments Finally Get Their Due A child’s hesitant question can disappear in the noise of a busy classroom, which is precisely why Teachstone’s latest recognition deserves more than the usual polite golf clap. The Charlottesville-based Certified B Corporation received a Bronze Anthem Award for its “From Measurement to Momentum” initiative, in the...

Continue Reading
Sogroya Approval Broadens Novo's Pediatric Growth Franchise

Updated Category News Views 14

Seven fewer injections every week is the real headline behind Novo Nordisk's latest FDA clearance, not some flashy efficacy leap. On November 20, 2026, the company said Sogroya, its once-weekly long-acting growth hormone, won approval for children aged 2.5 and older with growth failure associated with Turner syndrome. That matters because treatment can stretch over years,...

Continue Reading
AMD Faces Fresh Scrutiny Over China Supply Exposure

Updated Category News Views 18

One nasty report can turn a chip giant’s supply chain into a flashing red light, and that is precisely the mess confronting Advanced Micro Devices investors this week. Shares fell more than 7.7% on November 19 after Hunterbrook Media published allegations involving China-linked sales, firmware and manufacturing relationships. Then, on November 20, shareholder-rights...

Continue Reading
KidneyVoter Push Turns Patient Frustration Into Clout

Updated Category News Views 84

A ballot registration drive rarely tells the whole story, but it can reveal where the pressure is building. The American Association of Kidney Patients says its 2026 nonpartisan KidneyVoter™ effort, “50 States in 50 Days,” reached constituencies in every state after launching September 14. That does not produce a clean vote total or prove legislators will suddenly...

Continue Reading
Pinnacol’s Community Work Earns Denver Chamber Recognition

Updated Category News Views 27

A workers’ comp insurer usually becomes visible on somebody’s worst day; Pinnacol Assurance is being recognized for the work it keeps doing around those days. The Denver Metro Chamber of Commerce has given the Colorado-based, member-owned carrier its 2026 Business Impact Award for Corporate Social Responsibility. Awards can be cheap applause, frankly. This one...

Continue Reading
CASEKOO's Montana Story Makes Brand Purpose Personal

Updated Category News Views 19

A blurry Montana kitchen, not a glossy product render, is doing the heavy lifting for CASEKOO this Thanksgiving. That is either a smart bit of brand discipline or a sentimental detour, depending on whether the company can make people feel something without losing sight of why they bought a phone case in the first place. Warmth Takes the Place of Hardware CASEKOO's new...

Continue Reading
Pennsylvania Housing Finds Its October Holding Pattern

Updated Category News Views 79

Pennsylvania's October housing numbers have the uneasy stillness of a pond before somebody throws a rock. The statewide median sales price sat at $315,000, exactly where it was in September, while sales barely cleared 10,400 and available listings kept inching higher. Nothing in that mix screams boom or bust. Frankly, that is the point: a market can look calm on the...

Continue Reading
Fervo IPO Lawsuit Puts 71% Share Collapse in Focus

Updated Category News Views 36

Fervo’s $27 debut has turned into the sort of wreckage IPO buyers dread: shares were alleged to have closed as low as $7.79 when the complaint was filed. That is more than a 71% fall from the May 13, 2026 offering price, and it puts a hard, ugly number beside the new securities class action against the geothermal power developer. More Than a Bad Quarter Is Being Alleged...

Continue Reading
Trip.Best Expands Global Travel Discovery Footprint

Updated Category News Views 123

Sydney just became the map pin for a fairly serious travel-content land grab. Trip.Best, Trip.com Group's ranking brand, has rolled out its 2027 Annual Rankings with coverage of all seven continents for the first time. This is not an earnings release, and nobody should pretend a hotel list magically turns into revenue by lunchtime. Still, the jump from 85 to 98 annual...

Continue Reading

Top 5 Most Recently Viewed Articles

3D Marketing & Services, LLC Enhances Global Presence with RADIUM

Updated Category News Views 149

3D Marketing & Services, LLC Enhances Global Presence with RADIUM LIMITED In an exciting development, 3D Marketing & Services, LLC, a dynamic digital marketing and media distribution agency, proudly announces a transformative partnership with RADIUM LIMITED. This collaboration marks a significant growth milestone for 3D Marketing, emphasizing their commitment to deliver...

Continue Reading
Aerospace Riveting Equipment Market Expected to Surge

Updated Category News Views 88

Aerospace Riveting Equipment Market Expected to Surge The aerospace riveting equipment market is on an impressive growth trajectory. Estimates indicate that this sector, valued at USD 109 million in 2023, could reach as high as USD 134 million by 2028, expanding at a compound annual growth rate (CAGR) of 4.3% during this period. Numerous factors contribute to robust...

Continue Reading
Kinetic Seas CEO Edward Honour Reflects on Last Year's Growth

Updated Category News Views 309

Kinetic Seas CEO Edward Honour Reflects on Last Year's Growth Kinetic Seas (OTC: KSEZ) has charted a remarkable journey since we took operational control just over a year ago. I am Edward Honour, your CEO and Chairman of the Board. In this letter, I will share the inspiring story of our company's evolution and the challenges we overcame along the way. Our Vision and...

Continue Reading
Investigation into The Greenbrier Companies, Inc. by Investors

Updated Category News Views 351

Investigation Overview of The Greenbrier Companies Pomerantz LLP is currently conducting an investigation on behalf of the investors of The Greenbrier Companies, Inc. (NYSE: GBX). This inquiry seeks to uncover any possible securities fraud or unlawful practices involving the company's executives. Company Financial Performance The investigation follows Greenbrier's...

Continue Reading
Exploring Charles Schwab's Remarkable Growth Over Two Decades

Updated Category News Views 169

The Growth of Charles Schwab Over Twenty Years Charles Schwab (NYSE: SCHW) has shown remarkable performance over the last two decades, consistently outperforming the market. With an annualized growth rate that eclipses broader market returns by 1.21%, investors have witnessed an impressive average annual return of 10.08%. Investment Value After 20 Years Imagine if an...

Continue Reading